Cargando…

2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics

BACKGROUND: 90% of patients who report a penicillin allergy are not truly allergic and can safely receive penicillins. Patients labeled as “penicillin allergic” are more likely to receive non-beta lactam antibiotics and suffer worse clinical outcomes. In this study, we aimed to quantify the rate of...

Descripción completa

Detalles Bibliográficos
Autores principales: Martinez-Palmer, Meaghan, Khan, Parisa F, Xu, Teena
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Oxford University Press 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677552/
http://dx.doi.org/10.1093/ofid/ofad500.1824
_version_ 1785150156795019264
author Martinez-Palmer, Meaghan
Khan, Parisa F
Xu, Teena
author_facet Martinez-Palmer, Meaghan
Khan, Parisa F
Xu, Teena
author_sort Martinez-Palmer, Meaghan
collection PubMed
description BACKGROUND: 90% of patients who report a penicillin allergy are not truly allergic and can safely receive penicillins. Patients labeled as “penicillin allergic” are more likely to receive non-beta lactam antibiotics and suffer worse clinical outcomes. In this study, we aimed to quantify the rate of missed opportunities for penicillin allergy de-labeling in patients seen in ID clinic. METHODS: This single-center retrospective study identified patients with a documented penicillin allergy who attended an ID clinic appointment between 1/1/21 and 12/31/22. Allergy history was ascertained by chart review. Extracted data included date of reaction entry into the medical record, reaction type (IgE-mediated, unknown reaction, side effect, severe cutaneous adverse reactions/non-IgE-mediated), observed or historical reaction, severity of reaction, and documented tolerance of penicillin since initial reaction. Patients who had tolerated penicillins since reaction or had side effects were eligible for immediate de-labeling. Patients with unknown reactions, remote IgE-mediated allergies >10 years ago, or non-severe IgE-mediated allergies >5 years ago were considered candidates for further evaluation and penicillin allergy testing. All other reactions were considered ineligible for further evaluation. RESULTS: Of the 83 patients reviewed, 54 had reactions suggestive of an IgE-mediated allergy (Figure 1). 99% of patients had historical, self-reported reactions. At the time of ID clinic visit, 31 patients were eligible for immediate de-labeling due to tolerance of penicillins since reaction. Only 4 patients were ineligible for further evaluation. Median duration of penicillin allergy label was 18.8 years. 12 patients were ultimately de-labeled by the time of chart review. Figure 1 [Figure: see text] Types of Reactions CONCLUSION: 37% of patients with penicillin allergies seen in an ID clinic were eligible for immediate allergy de-labeling. These findings demonstrate a high rate of missed opportunities for ID providers to remove penicillin allergies during clinic visits. DISCLOSURES: All Authors: No reported disclosures
format Online
Article
Text
id pubmed-10677552
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher Oxford University Press
record_format MEDLINE/PubMed
spelling pubmed-106775522023-11-27 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics Martinez-Palmer, Meaghan Khan, Parisa F Xu, Teena Open Forum Infect Dis Abstract BACKGROUND: 90% of patients who report a penicillin allergy are not truly allergic and can safely receive penicillins. Patients labeled as “penicillin allergic” are more likely to receive non-beta lactam antibiotics and suffer worse clinical outcomes. In this study, we aimed to quantify the rate of missed opportunities for penicillin allergy de-labeling in patients seen in ID clinic. METHODS: This single-center retrospective study identified patients with a documented penicillin allergy who attended an ID clinic appointment between 1/1/21 and 12/31/22. Allergy history was ascertained by chart review. Extracted data included date of reaction entry into the medical record, reaction type (IgE-mediated, unknown reaction, side effect, severe cutaneous adverse reactions/non-IgE-mediated), observed or historical reaction, severity of reaction, and documented tolerance of penicillin since initial reaction. Patients who had tolerated penicillins since reaction or had side effects were eligible for immediate de-labeling. Patients with unknown reactions, remote IgE-mediated allergies >10 years ago, or non-severe IgE-mediated allergies >5 years ago were considered candidates for further evaluation and penicillin allergy testing. All other reactions were considered ineligible for further evaluation. RESULTS: Of the 83 patients reviewed, 54 had reactions suggestive of an IgE-mediated allergy (Figure 1). 99% of patients had historical, self-reported reactions. At the time of ID clinic visit, 31 patients were eligible for immediate de-labeling due to tolerance of penicillins since reaction. Only 4 patients were ineligible for further evaluation. Median duration of penicillin allergy label was 18.8 years. 12 patients were ultimately de-labeled by the time of chart review. Figure 1 [Figure: see text] Types of Reactions CONCLUSION: 37% of patients with penicillin allergies seen in an ID clinic were eligible for immediate allergy de-labeling. These findings demonstrate a high rate of missed opportunities for ID providers to remove penicillin allergies during clinic visits. DISCLOSURES: All Authors: No reported disclosures Oxford University Press 2023-11-27 /pmc/articles/PMC10677552/ http://dx.doi.org/10.1093/ofid/ofad500.1824 Text en © The Author(s) 2023. Published by Oxford University Press on behalf of Infectious Diseases Society of America. https://creativecommons.org/licenses/by/4.0/This is an Open Access article distributed under the terms of the Creative Commons Attribution License (https://creativecommons.org/licenses/by/4.0/), which permits unrestricted reuse, distribution, and reproduction in any medium, provided the original work is properly cited.
spellingShingle Abstract
Martinez-Palmer, Meaghan
Khan, Parisa F
Xu, Teena
2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title_full 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title_fullStr 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title_full_unstemmed 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title_short 2202. Missed Opportunities for Penicillin Allergy De-labeling in Infectious Disease Clinics
title_sort 2202. missed opportunities for penicillin allergy de-labeling in infectious disease clinics
topic Abstract
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10677552/
http://dx.doi.org/10.1093/ofid/ofad500.1824
work_keys_str_mv AT martinezpalmermeaghan 2202missedopportunitiesforpenicillinallergydelabelingininfectiousdiseaseclinics
AT khanparisaf 2202missedopportunitiesforpenicillinallergydelabelingininfectiousdiseaseclinics
AT xuteena 2202missedopportunitiesforpenicillinallergydelabelingininfectiousdiseaseclinics